Oracle, Shares

Oracle Shares Surge Following Analyst Upgrade and Strategic Wins

14.01.2026 - 04:43:03

Oracle US68389X1054

Oracle Corporation's stock momentum continues to build, with shares climbing 3.5% on Tuesday. This uptick was catalyzed by Goldman Sachs upgrading its rating on the software giant to "Strong-Buy." The positive shift in sentiment coincides with the company announcing significant new client engagements in the healthcare and retail sectors, key areas for its AI-powered cloud offerings. The recent gain suggests investor confidence is recovering after a sell-off in December.

Over the weekend, Oracle secured two notable strategic victories. Community Memorial Hospital in New York selected Oracle's suite of AI-driven health solutions, which includes a voice-activated system for automated clinical data documentation. This agreement highlights the ambitions of the Oracle Health division, led by Seema Verma.

Concurrently, at the NRF 2026 conference in New York, the company unveiled a new AI-based supply chain platform for retailers. The solution leverages predictive analytics and real-time alerts to optimize logistics, addressing a critical pain point for global merchants.

Analyst Consensus Turns Bullish

Goldman Sachs justified its upgraded stance by pointing to Oracle's formidable positioning within the AI infrastructure market. This view aligns with a series of optimistic assessments from other research firms:

  • Jefferies maintains a price target of $400.
  • HSBC reaffirmed a $382 target in November.
  • Bank of America continues with a "Buy" rating, though it adjusted its price objective to $300 from a previous $368.

The consensus average price target now stands at $305.50, approximately 50% above the current trading level. The stock's price-to-earnings (P/E) ratio of 38 reflects substantial growth expectations.

Should investors sell immediately? Or is it worth buying Oracle?

Rebound from Quarterly Disappointment

Since mid-December lows, Oracle's equity has appreciated roughly 15%. The earlier decline was triggered by second-quarter results released on December 10th, where revenue narrowly missed estimates ($16.06 billion actual vs. $16.19 billion expected). However, underlying growth metrics were robust:

  • Cloud infrastructure revenue jumped 68% to $4.1 billion.
  • Multicloud revenue soared by 817%.
  • Remaining Performance Obligations (RPO) surged 438% to $523 billion.

The massive RPO growth is partly driven by large-scale commitments from clients like Meta, NVIDIA, and OpenAI. The latter companies have collectively committed to contracts worth $300 billion.

Not All Voices Are Convinced

Despite the optimism, some maintain a cautious outlook. Investor Michael Burry has established short positions against Oracle, citing the company's debt load, estimated between $95 and $108 billion. Furthermore, Oracle has raised its capital expenditure forecast for the current fiscal year to $50 billion, up from $35 billion, to expand data center capacity. The return on this substantial investment remains to be seen.

Insider selling has also been noted. CEO Clayton Magouyrk disposed of 40,000 shares at $276.64 each in October, while board member Naomi Seligman sold 2,223 shares at $196.61.

Forward Guidance and Shareholder Returns

For its fiscal third quarter, Oracle projects revenue growth of 19% to 20%, with cloud-specific growth anticipated between 40% and 44%. Adjusted earnings per share are forecast in the range of $1.70 to $1.74. Analysts project full-year EPS around $5.00. The company's next quarterly report is expected in early March. Additionally, Oracle will distribute a dividend of $0.50 per share on January 23rd.

Ad

Oracle Stock: Buy or Sell?! New Oracle Analysis from January 14 delivers the answer:

The latest Oracle figures speak for themselves: Urgent action needed for Oracle investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from January 14.

Oracle: Buy or sell? Read more here...

@ boerse-global.de | US68389X1054 ORACLE